SUMMARY Sera from patients attending a sexually transmitted diseases (STD) clinic, a family planning clinic, and an antenatal clinic in Ibadan, Nigeria, as well as from male blood donors from the same area were tested for the presente of type specific antichlamydial antibodies using a modified micro-immunofluorescence test.
Introduction
In the developed countries of the West, the prevalence of non-gonococcal genital infections (NGGI) is higher than that of gonococcal genital infection.' 2 Although no accurate figures are available for most of the developing countries it has been estimated that NGGI are as prevalent in these areas as in the West. 34 Studies have shown that in developed countries Chlamydia trachomatis is responsible for up to 68% of cases of non-gonococcal urethritis in men5 and has been isolated from the cervix of up to 31 % of women attending sexually transmitted diseases (STD) clinics.6 In this study we Antibodies to C trachomatis serotypes A to C (trachoma types) were found in a total of 22 of 678 (3* 2%b) sera from all groups, and antibodies to lymphogranuloma venereum (LGV) types were detected in only two (0-3%) (both from men). Antibodies against Chlamydia psittaci serotypes were not detected.
Discussion
The patients attending the STD clinic, Ibadan, presented with a variety of genital diseases. The diagnoses made in these patients included syphilis, gonorrhoea, non-gonococcal urethritis, cervicitis, 10 11 * 8% of men and 22 v 707o of women from this clinic in Ibadan appeared to have active chlamydial genital infections at the time of examination. In a previous study from the same clinic, 26%o of all patients had NGGI." Our results suggest that most of these infections may be due to chlamydiae and that women are the main resevoir of infection.
Perhaps the most striking finding of this study is that among 160 women attending a family clinic in Ibadan antibodies to C trachomatis serotypes D to K were detected in 35%o. Of these 25%o had antibody titres suggesting active infection. This prevalence is higher than would be expected in the United Kingdom or USA, where 3%7o and l17o of women attending family planning clinics had chlamydial genital infections.6 12 The titres of IgG among these women in Ibadan (GMT 1/72) were similar to those in the women attending the STD clinic and to those in women in the United Kingdom with chlamydial genital infections.'0 Of 155 women presenting for routine antenatal examinations antibodies to serotypes D to K were found in the sera of 10-307o. Although the IgG was generally of a low titre (GMT 1/29), 3 9%o of these women had values suggesting active infection. Similarly, among 101 male blood donors, 9 9%o had these antibodies (GMT 1/21) and 50o had evidence of active infection. By comparison, using the same serological test in the United Kingdom we found IgG antibody to C trachomatis serotypes D to K in only 3% of female and less than 1% of male blood donors.'3 Antichlamydial IgM could not be detected in sera from these blood donors in the UK.
Only two patients, both men, had antibodies to LGV serotypes, indicating a very low prevalence of exposure (less than 1070) in this population. This finding agrees with a previous study in Nigeria, where among patients with STD the prevalence of LGV was also found to be low at 2'5 7o.3 Few patients (3qo) in Ibadan had antibodies specific for C trachomatis serotypes A to C, the types commonly associated with hyperendemic trachoma.14 In Nigeria tetracycline is widely available and commonly abused through self-medication for minor ailments. Although chlamydiae are sensitive to this antibiotic the seroreactivity to C trachomatis serotypes D to K was high among the patients studied. Our 
